Elmar Aigner

ORCID: 0000-0003-0310-0536
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Iron Metabolism and Disorders
  • Liver Diseases and Immunity
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • Endoplasmic Reticulum Stress and Disease
  • Protease and Inhibitor Mechanisms
  • Hemoglobinopathies and Related Disorders
  • Trace Elements in Health
  • Colorectal Cancer Screening and Detection
  • Alcohol Consumption and Health Effects
  • Hepatitis C virus research
  • Peptidase Inhibition and Analysis
  • Diet and metabolism studies
  • Folate and B Vitamins Research
  • Pediatric Hepatobiliary Diseases and Treatments
  • Helicobacter pylori-related gastroenterology studies
  • Nutritional Studies and Diet
  • Gastric Cancer Management and Outcomes
  • Adipose Tissue and Metabolism
  • Lysosomal Storage Disorders Research
  • Hepatitis B Virus Studies
  • Metabolomics and Mass Spectrometry Studies
  • Cardiovascular Health and Risk Factors
  • Cardiovascular Disease and Adiposity

Paracelsus Medical University
2016-2025

Universitätskliniken Salzburg
2017-2025

Salzburger Landeskliniken
2010-2025

University of Salzburg
2012-2024

Leuphana University of Lüneburg
2024

Unfallkrankenhaus Salzburg
2018-2023

Swiss Federal Institute of Aquatic Science and Technology
2023

Gesundheit Österreich
2023

Istituti di Ricovero e Cura a Carattere Scientifico
2022

Ospedale Maggiore
2022

Zobair M. Younossi Vlad Ratziu Rohit Loomba Mary E. Rinella Quentin M. Anstee and 95 more Zachary Goodman Pierre Bédossa Andreas Geier Susanne Beckebaum Philip N. Newsome David Sheridan Muhammad Y. Sheikh James F. Trotter W Knapple Eric Lawitz Manal F. Abdelmalek Kris V. Kowdley Aldo J. Montaño‐Loza Jérôme Boursier Philippe Mathurin Elisabetta Bugianesi G. Mazzella Antonio Olveira Helena Cortez‐Pinto Isabel Graupera David Orr Lise Lotte Gluud Jean‐François Dufour David E. Shapiro Jason Campagna Luna Zaru Leigh MacConell Reshma Shringarpure Stephen A. Harrison Arun J. Sanyal Manal F. Abdelmalek Gary A. Abrams Humberto Aguilar Aijaz Ahmed Elmar Aigner Guruprasad P. Aithal Aftab Ala William Alazawi Agustı́n Albillos Michael Allison Sfa Al-Shamma Raúl J. Andrade Pietro Andreoné M. Angélico Victor Ankoma‐Sey Quentin M. Anstee Rodolphe Anty Víctor Araya Juan Ignacio Arenas Ruiz Perttu Arkkila Marty Arora Tarik Asselah Jennifer Au Oyekoya T. Ayonrinde Robert J. Bailey Maya Balakrishnan Kiran Bambha Meena B. Bansal Sidney Barritt John Bate Jorge Beato Susanne Beckebaum Jaideep Behari Pablo Bellot Ziv Ben Ari Michael Bennett Marina Berenguer Benedetta Terziroli Beretta‐Piccoli Thomas Berg Maurizio Bonacini Lucía Bonet Brian B. Borg Marc Bourlière Jérôme Boursier William D. Bowman David Bradley Marija Branković Marius Braun Jean-Pierre Bronowicki Savino Bruno Elisabetta Bugianesi Cindy X. Cai Amy Calderon José Luís Calleja Elizabeth J. Carey Michal Carmiel J.A. Carrión Matthew C. Cave Cristina Chagas Tawfik N. Chami Alan K. Chang Allan Coates Jeremy Cobbold Charlote Costentin Kathleen E. Corey

10.1016/s0140-6736(19)33041-7 article EN The Lancet 2019-12-01

Non-alcoholic fatty liver disease (NAFLD) is closely linked to obesity; however, 5-8% of lean subjects also have evidence NAFLD. We aimed investigate clinical, genetic, metabolic and lifestyle characteristics in Caucasian with NAFLD.Data from 187 allocated one the three groups according body mass index (BMI) hepatic steatosis on ultrasound were obtained: healthy (BMI≤25 kg/m2, no steatosis, N=71), NAFLD N=55), obese (BMI≥30 steatosis; N=61). All received a detailed clinical laboratory...

10.1038/ajg.2016.318 article EN The American Journal of Gastroenterology 2016-08-16

Excess free iron is a substrate for the formation of reactive oxygen species (ROS), thereby augmenting oxidative stress. Oxidative stress well-established cause organ damage in liver, main site storage. Ferroptosis, an iron-dependent mechanism regulated cell death, has recently been gaining attention development and progression liver disease. We therefore summarize mechanisms metabolism, its close connection to ferroptosis, particular relevance disease metabolic-dysfunction-associated fatty...

10.3390/antiox13020208 article EN cc-by Antioxidants 2024-02-07

Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by systemic inflammation. While RA primarily affects the joints, its effects may lead to an increased cerebro- and cardiovascular risk. Atherosclerosis of carotid arteries significant risk factor for cerebrovascular events serves as surrogate marker This study explores link between artery atherosclerosis with data from Paracelsus 10,000 Study. Baseline assessments were conducted on individuals randomly selected Salzburg...

10.1007/s00296-024-05781-4 article EN cc-by Rheumatology International 2025-01-18

Copper has a role in antioxidant defense, lipid peroxidation, and mitochondrial function, copper deficiency been linked to atherogenic dyslipidemia. We aimed investigate the potential of availability pathogenesis nonalcoholic fatty liver disease (NAFLD).Patients with NAFLD (n=124) were compared patients chronic hepatitis C (n=50), hemochromatosis (n=35), alcoholic (n=13), autoimmune (n=11), control subjects (n=27). determined serum concentrations correlation clinical, histological,...

10.1038/ajg.2010.170 article EN The American Journal of Gastroenterology 2010-04-20

Wilson disease (WD) is an inherited disorder of hepatic copper metabolism with considerable variation in clinical presentations, the most common ones being liver and neuropsychiatric disturbances. This study investigated presentation relation to mutations a large cohort patients WD. A total 1,357 (702 children, 655 adults; 1,172 index patients, 185 siblings, all Leipzig score ≥4, male/female: 679/678) were studied. The age symptoms at used as key phenotypic markers. Index clinically...

10.1002/hep.30280 article EN Hepatology 2018-09-20

Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of insulin resistance (IR), and IR associated with an increased risk colorectal carcinoma (CRC). Increased echogenicity suggesting NAFLD a frequent incidental finding on ultrasound examination. We aimed to systematically evaluate whether independent factor for colonic neoplasia.One thousand two hundred eleven patients (603 males, 60.6 ± 9.6 years; 608 females, 61.1 10.3 years) who underwent screening colonoscopy according...

10.1111/j.1365-2796.2011.02377.x article EN Journal of Internal Medicine 2011-03-17

Objective Homozygous alpha1-antitrypsin (AAT) deficiency increases the risk for developing cirrhosis, whereas relevance of heterozygous carriage remains unclear. Hence, we evaluated impact two most relevant AAT variants (‘Pi*Z’ and ‘Pi*S’), present in up to 10% Caucasians, on subjects with non-alcoholic fatty liver disease (NAFLD) or alcohol misuse. Design We analysed multicentric case–control cohorts consisting 1184 people biopsy-proven NAFLD 2462 chronic misuse, both comprising cases...

10.1136/gutjnl-2018-316228 article EN Gut 2018-08-01

A small proportion of lean patients develop non-alcoholic fatty liver disease (NAFLD). We aimed to report the histological picture NAFLD in comparison overweight and obese patients. Biopsy clinical data from 466 diagnosed with were stratified groups according body mass index (BMI): (BMI ≤ 25.0 kg/m², n confirmed be appropriate = 74), > 30.0 242) 150). Lean had a higher rate lobular inflammation compared (12/74; 16.2% vs. 19/242; 7.9%; p 0.011) but similar (25/150; 16.7%). Ballooning was...

10.3390/jcm7120562 article EN Journal of Clinical Medicine 2018-12-17

The rs641738C>T variant located near the membrane-bound O-acyltransferase domain containing 7 (MBOAT7) locus is associated with fibrosis in liver diseases, including non-alcoholic fatty disease (NAFLD), alcohol-related disease, hepatitis B and C. We aim to understand mechanism by which contributes pathogenesis of NAFLD.

10.1136/gutjnl-2020-320853 article EN cc-by-nc Gut 2020-06-26
Coming Soon ...